DESIGN AND DEVELOPMENT OF <em>NICOTIANA TABACUM</em> FILM USING FACTORIAL DESIGN

Authors

  • Anwar Daud Department of Pharmaceutical Science, NIMS University, Jaipur
  • Ashok Peepliwal Department of Pharmaceutical Science, NIMS University, Jaipur
  • Minal Bonde Zim Laboratories Ltd., Nagpur-441501
  • Nidhi Sapkal Gurunanak College of Pharmacy, Nagpur
  • Naresh Gaikwad Department of Pharmaceutical Science, RTM Nagpur University, Nagpur, India
  • C. B. Gunawardena

Keywords:

Nicotianna tabacum, Factorial designs, Pilot scale clinical efficacy studies

Abstract

Objective: The objective of the present investigation was to develop and optimize Nicotiana tabacum oral dissolving films with optimized physicomechanical and chemical properties for improved patient compliance. Nicotiana tabacum oral dissolving films are used to help people stop smoking cigarettes.

Methods: Nicotiana tabacum oral dissolving films were prepared by solvent casting method using hydroxymethylpropyl cellulose as film forming polymer and polyethylene glycol 6000 as a surfactant. The process was optimized using the design of experiments. Four process parameters were studied at two levels using 24 design. Further, the optimized Nicotiana tabacum oral dissolving films were evaluated for HPTLC analysis, microbial limit test, organoleptic evaluation, stability studies and clinical efficacy studies.

Results: It was found that the thickness of wet film and viscosity of solution has a significant influence on thickness as well as disintegration time. Folding endurance and tensile strength of the film was influenced by the thickness of the wet film, machine speed and viscosity of the solution. Drying temperature does not have any significant influence on the selected response. By controlling the thickness of wet film 0.5 mm, the viscosity of the solution 5000 cps and machine speed 15 min, disintegration time, folding endurance and tensile strength of this formulation can be controlled.

Conclusion: It was noted that Nicotiana tabacum oral dissolving films are being accepted by patients in general and showed a marked reduction in craving for smoking. Prepared formulation was stable for 6 mo stability as per ICH guidelines.

Downloads

Download data is not yet available.

References

Moore D, Aveyard P, Connock M, Wang D, Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. Br Med J 2009;338:1024-7.

Hecht SS. Tobacco smoke carcinogens and lung cancer. Cancer Inst 1991;91 Suppl 14:1194-210.

Siemann U. Solvent cast technology–a versatile tool for thin film production. Prog Colloid Polym Sci 2005;130:1–14.

Kris H, Dave V, Arnout E, Wim W, Annick L. Full factorial design, physicochemical characterization and biological assessment of cyclosporine A loaded cationic nanoparticles. Eur J Pharm Biopharm 2012;82 Suppl 1:27-35.

Patel R, Naik S, Patel J, Baria A. Formulation development and evaluation of mouth melting film of ondansetron. Arch Pharm Sci Res 2009;1 Suppl 2:212-7.

L, O'Donnell P, McGinity J. Mechanical properties of polymeric films prepared from aqueous dispersions. In: Felton ML. editors, Aqueous polymeric coatings for pharmaceutical dosage forms. 3rd edition. New York: McGraw-Hill; 2005. p. 108.

Fulzele SV, Sattuwar PM, Dorle AK. Polymerized rosin: novel film forming polymer for drug delivery. Int J Pharm 2002;249:175–84.

Shinde AJ, Garala KC, More HN. Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm 2008;2 Suppl 4:265–9.

Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm 2009;368(1, Suppl 2):98–102.

Behin SR, Isaac SP, Fels S. Development of matrix dispersion transdermal therapeutic system containing glipizide. Pharm Lett 2013,5 Suppl 3:278-86.

Cilureo F, Cupone I, Minghtti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 2008;70:895-900.

Kaushik Sunil, Khan N, Ahmad S, Singh M, Gupta S, Semwal A, et al. Comparative pharmacognostical evaluation and HPTLC fingerprinting of Nicotiana tabacum (Linn.) root collected from different geographical regions of India. Cent Eur J Exp Biol 2012;1 Suppl 1:18-25.

Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 2005;31:25-34.

Sheikh S, Asghar S, Ahmad S. HPTLC method development and validation for the estimation of 6-gingerol in oral thin film. Int J Pharm Biol Sci 2013;4 Suppl 2:93-8.

Guidance for Industry Q1A (R2) Stability Testing of New Drug Substances and Products; 2003.

Liew KB, Tan YTF, Peh KK. Characterization of oral disintegrating film containing Donepezil for alzheimer disease. AAPS PharmSciTech 2012;13 Suppl 1:134-42.

Tingsatnd JE. Physical stability testing of pharmaceuticals. J Pharm Sci 1964;53:955-62.

Indian Pharmacopoeia. 6th ed. Indian Pharmacopoeia Commission. Ministry of health and family welfare, Government of India; 2008. p. 223-8.

Dinge A, Nagarsenkar M. Formulation and evaluation of fast dissolving films for delivery of triclosan to oral cavity. AAPS PharmaSciTech 2008;9:349-56.

Bruce C, Manning M. Inventor; Melt extruded thin strips containing coated pharmaceutical actives. WO 2011081625 A1; 2011.

Greener J, Ng KC, Vaeth KM, Smith TM. Moisture permeability through multilayered barrier films as applied to flexible OLED display. J Appl Polym Sci 2007;106:3534–42.

Published

01-08-2016

How to Cite

Daud, A., A. Peepliwal, M. Bonde, N. Sapkal, N. Gaikwad, and C. B. Gunawardena. “DESIGN AND DEVELOPMENT OF <em>NICOTIANA TABACUM</Em> FILM USING FACTORIAL DESIGN”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 8, Aug. 2016, pp. 115-23, https://journals.innovareacademics.in/index.php/ijpps/article/view/11864.

Issue

Section

Original Article(s)